Clinical Review

Racial Differences in Adherence to Prescribed Analgesia in Cancer Patients: An Integrated Review of Quantitative Research

Journal of Clinical Outcomes Management. 2017 January;24(1)

Author(s):

References

1. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. JAMA 2016;315:1624–45.

2. Meghani SH, Knafl GJ. Patterns of analgesic adherence predict health care utilization among outpatients with cancer pain. Patient Prefer Adher 2016;10:81–98.

3. Bryan M, De La Rosa N, Hill AM, et al. Influence of prescription benefits on reported pain in cancer patients. Pain Med 2008;9:1148–57.

4. Rhee YO, Kim E, Kim B. Assessment of pain and analgesic use in African American cancer patients: Factors related to adherence to analgesics. J Immigr Minor Health 2012;14:1045–51.

5. Laird BJ, Scott AC, Colvin LA, et al. Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Symptom Manage 2011;42:1–11.

6. Ferreira KA, Kimura M, Teixeira MJ, et al. Impact of cancer-related symptom synergisms on health-related quality of life and performance status. J Pain Symptom Manage 2008;35:604–16.

7. Craig BM, Strassels SA. Out-of-pocket prices of opioid analgesics in the United States, 1999-2004. Pain Med 2010;11:240–47.

8. Institute of Medicine: Relieving pain in america: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press; 2011.

9. Institutes of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: National Academies Press; 2003.

10. Meghani SH, Byun E, Gallagher RM. Time to take stock: A meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. Pain Med 2012;13:150–74.

11. Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med 1997;127:813–6.

12. Nguyen LMT, Rhondali W, De la Cruz M, et al. Frequency and predictors of patient deviation from prescribed opioids and barriers to opioid pain management in patients with advanced cancer. J Pain Symptom Manage 2013;45:506–16.

13. Meghani SH, Thompson AML, Chittams J, et al. Adherence to analgesics for cancer pain: A comparative study of African Americans and whites using an electronic monitoring device. J Pain 2015;16:825–35.

14. Weider R, DeLaRosa N, Bryan M, et al. Prescription coverage in indigent patients affects the use of long acting opioids in management of cancer pain. Pain Med 2014;15:42–51.

15. Meghani SH, Brune DW. A pilot study to identify correlates of intentional versus unintentional nonadherence. Pain Manag Nurs 2013;14:e22-30.

16. Anderson KO, Mendoza TR, Valero V, et al. Minority cancer patients and their providers: pain management attitudes and practice. Cancer 2000;88:1929–38.

17. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52:377–84.

18. Ward SE, Goldberg N, Miller-McCauley V, et al. Patient-related barriers to management of cancer pain. Pain 1993;52:319–24.

19. Glare PA, Davies PS, Finlay E, et al. Pain in cancer survivors. J Clin Oncol 2014;32:1739–47.

20. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007;18:1437–49.

21. Jacobsen R, Samsanaviciene J, Liubarskiene Z, et al. Barriers to cancer pain management in Danish and Lithuanian patients treated in pain and palliative care units. Pain Manag Nurs 2014; 15:51–8.

22. National Institutes of Health. Pathways to prevention: the role of opioids in the treatment of chronic pain. September 29–30, 2014. Executive summary: final report. Accessed 10 Sep 2015 at https://prevention.nih.gov/docs/programs/p2p/ODPPainPanelStatementFinal_10-02-14.pdf.

23. Miaskowski C, Dodd MJ, West C, et al. Lack of adherence with the analgesic regimen: A significant barrier to effective cancer pain management. J Clin Oncol 2001;19:4275–79.

24. Yoong J, Traeger LN, Gallagher ER, et al. A pilot study to investigate adherence to long-acting opioids among patients with advanced lung cancer. J Palliat Med 2013;16:391–6.

25. Lai YH, Keefe FJ, Sun WZ, et al. Relationship between pain-specific beliefs and adherence to analgesic regimens in Taiwanese cancer patients: A preliminary study. J Pain Symptom Manage 2002;24:415–22.

26. Cohen MZ, Musgrave CF, McGuire DB, et al. The cancer pain experience of Israeli adults 65 years and older: the influence of pain interference, symptom severity, and knowledge and attitudes on pain and pain control. Support Care Cancer 2005;13:708–14.

27. Bennett MI, Bagnall AM, Jose Closs S. How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta analysis. Pain 2009;143:192–9.

28. Oldenmenger WH, Sillevis Smitt PA, van Dooren S, et al. A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal. Eur J Cancer 2009;45:1370–80.

29. Meghani SH, Chittams J. Controlling for socioeconomic status in pain disparities research: all-else-equal analysis when “all else” is not equal. Pain Med 2015;16:2222–5.

30. Meghani SH, Chittams J, Hanlon A, Curry J. Measuring preferences for analgesic treatment for cancer pain: how do African Americans and whites perform on choice-based conjoint analysis experiments? BMC Med Inform Decis Mak 2013;13:118.

31. Meghani SH, Kang Y, Chittams J, et al. African Americans with cancer pain are more likely to receive an analgesic with toxic metabolite despite clinical risks: a mediation analysis study. J Clin Oncol 2014;32:2773–9.

32. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids forchronic pain - United States, 2016. MMWR Recomm Rep 2016 Mar 18;65:1–49.

33. Chapman CR, Lipschitz DL, Angst MS, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain 2010;11:807–29.

From the University of Pennsylvania School of Nursing, Philadelphia, PA.

Abstract

Background: Racial/ethnic disparities in analgesic treatment for pain have been widely documented in the United States. However, the connection between race/ethnicity and adherence to prescribed analgesics has not been described.
Objectives: To review and synthesize quantitative research documenting racial/ethnic differences in adherence to prescribed analgesia in cancer patients.
Methods: We performed a systematic search of quantitative, primary studies in Scopus, CINAHL, PubMed, Ovid, PsychInfo, and EMBASE. The title and abstract of each article was reviewed for relevance and whether inclusion criteria were met. Evidence was examined for relevant outcomes, data collection methods, variables studied in relation to adherence, and the magnitude of association between race/ethnicity and adherence.
Results: Seven studies met inclusion criteria. Reported rates of adherence varied in studies among Hispanic/Latinos, African Americans, Asians, and whites based on variation in measurement tools, research questions, populations from which participants were recruited, and predictive variables analyzed. Most existing studies of analgesic adherence used self-report to measure adherence. Only 1 study used a validated, real-time electronic instrument to monitor prescribed opioid adherence and had a longitudinal study design.
Conclusion: Limited research has examined relationships between adherence to prescribed analgesic regimens and racial disparities. Existing studies point to the clinical and socioeconomic factors that may interact with race/ethnicity in explaining analgesic and opioid adherence outcomes in cancer patients.

Key words: race, ethnicity, adherence, opiates, analgesics, pain management, cancer, pain treatment disparities.

The ongoing opioid epidemic and recent development of the Centers for Disease Control and Prevention (CDC) guidelines for chronic pain management have shaped a national conversation on opioid prescription and utilization [1]. The CDC delineates provider recommendations for opioid prescription. This focus on prescribed medication regimens is inadequate without an understanding of how patients take or adhere to prescribed medications. Cancer patients are a unique group. Moderate to severe pain in cancer patients is usually treated with opioids, and adherence to analgesia has been conceptualized a key mediator of cancer pain outcomes. For instance, a recent study found that patterns of analgesic adherence, specifically, inconsistent adherence to strong opioids (World Health Organization step 3), is one of the strongest predictors of health care utilization among outpatients with cancer pain [2]. Approximately 67% to 77% of cancer patients experience pain that requires management with analgesia [3], especially in the absence of access to nonpharmacologic pain treatments [2]. Thus, barriers in relation to adequate pain management can result in poor pain treatment outcomes and impaired quality of life for cancer patients.

Insufficient pain management has been found to have a negative impact on the quality of life and physical and mental functions of patients with cancer [4]. Patients who experience severe cancer pain are significantly more likely to experience multiple other symptoms such as depression, fatigue, and insomnia, resulting in diminished physical function [5], social role function [6], and greater out of pocket cost of managing pain and asso-ciated symptoms [7]. Minority populations, however, disproportionately carry the burden of undertreated pain [4,8–11,13–16]. Evidence suggests that blacks/African Americans are more likely to experience unrelieved cancer pain [4,8–11,13–16]. They are also less likely than their white counterparts to receive analgesic treatment for cancer pain [8–11,13,15,16]. Little is known, however, about racial disparities in relation to adherence to analgesia for cancer pain when providers prescribe analgesics.